These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19572419)

  • 1. [The HIV replication cycle. Established therapeutic targets and potential targets].
    Alcamí J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():3-10. PubMed ID: 19572419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How proviral DNA is integrated into the host cell DNA and how this process can be inhibited].
    Mirambeau G
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():11-6. PubMed ID: 19572420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrroloaryls and pyrroloheteroaryls: Inhibitors of the HIV fusion/attachment, reverse transcriptase and integrase.
    Patel RV; Park SW
    Bioorg Med Chem; 2015 Sep; 23(17):5247-63. PubMed ID: 26116177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 antiretroviral drug therapy.
    Arts EJ; Hazuda DJ
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a007161. PubMed ID: 22474613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New targets and new drugs in the treatment of HIV.
    López-Aldeguer J; Aguirrebengoa K; Arribas JR; Esté JA; Kindelán JM
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():25-40. PubMed ID: 16373002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stages of HIV replication and targets for therapeutic intervention.
    Tözsér J
    Curr Top Med Chem; 2003; 3(13):1447-57. PubMed ID: 14529520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in anti-HIV chemotherapy.
    De Clercq E
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):258-75. PubMed ID: 12084468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.
    Murray JM; Emery S; Kelleher AD; Law M; Chen J; Hazuda DJ; Nguyen BY; Teppler H; Cooper DA
    AIDS; 2007 Nov; 21(17):2315-21. PubMed ID: 18090280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting HIV attachment and entry for therapy.
    Strizki J
    Adv Pharmacol; 2008; 56():93-120. PubMed ID: 18086410
    [No Abstract]   [Full Text] [Related]  

  • 12. New targets for inhibitors of HIV-1 replication.
    Moore JP; Stevenson M
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):40-9. PubMed ID: 11413488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].
    Llibre JM; Martínez-Picado J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotides as inhibitors of human immunodeficiency virus.
    Field AK
    Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.
    de Soultrait VR; Desjobert C; Tarrago-Litvak L
    Curr Med Chem; 2003 Sep; 10(18):1765-78. PubMed ID: 12871103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher antiviral activity of antiretroviral regimens including protease inhibitors.
    de Mendoza C; Soriano V; Rodríguez-Rosado R; González-Lahoz J
    AIDS; 1999 May; 13(8):998-9. PubMed ID: 10371186
    [No Abstract]   [Full Text] [Related]  

  • 18. New antiretroviral drugs, part II: NRTIs, NNRTIs, and beyond.
    Murphy RL
    AIDS Clin Care; 1999 Jun; 11(6):47-9, 51, 53-4. PubMed ID: 11366882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The daunting challenge of keeping HIV suppressed.
    Cohen J
    Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768
    [No Abstract]   [Full Text] [Related]  

  • 20. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
    Witvrouw M; Debyser Z
    Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.